The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

The Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...

Dr Pavan Bhargava comments on the practical implications of the revised diagnostic criteria, which allow for earlier diagnosis.

At Root Cause Integrative Wellness in Berea, alternative therapies rooted in the natural world are gaining attention for ...

By studying the effects of the nasal anti-CD3 in a ... Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped ...

Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

Early treatment with Ocrevus may help protect the cerebellum from damage in people with multiple sclerosis, a study found.

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...

Several immune cells are involved in those attacks, including B-cells ... a CD19 CAR T Cell Therapy, in Participants with Treatment Refractory Progressive Multiple Sclerosis.” ...

Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

An experimental drug can help patients with advanced multiple sclerosis delay the progressive ... Clinic's Mellen Center for MS Research and Treatment. Tolebrutinib is under review by the U.S ...